These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9750882)

  • 1. Financial impact of Denmark's decision to restrict use of high-osmolar contrast media.
    Thomsen HS
    Acad Radiol; 1998 Sep; 5 Suppl 2():S450-3. PubMed ID: 9750882
    [No Abstract]   [Full Text] [Related]  

  • 2. The financial impact of Denmark's decision to restrict the use of high-osmolar contrast media in intravascular radiographic procedures.
    Thomsen HS; Archer JW; Schiermer L; Radensky PW
    Eur Radiol; 1998; 8(2):321-2. PubMed ID: 9477291
    [No Abstract]   [Full Text] [Related]  

  • 3. A case study of the decision in Denmark to restrict use of high-osmolar contrast media in intravascular radiographic procedures.
    Thomsen HS; Archer JW; Schiermer L; Radensky PW
    Acad Radiol; 1997 Jun; 4(6):446-50. PubMed ID: 9189203
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast media costs can be reduced still more.
    Campbell JW
    Hosp Mater Manage; 1997 May; 22(5):12. PubMed ID: 10167086
    [No Abstract]   [Full Text] [Related]  

  • 5. Universal use of low-osmolar contrast media: a European perspective.
    Thomsen HS
    Acad Radiol; 1994 Nov; 1(3):295-7. PubMed ID: 9419502
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful use of education and cost-based feedback strategies to reduce physician utilization of low-osmolality contrast agents in the cardiac catheterization laboratory.
    Ziskind AA; Portelli J; Rodriguez S; Stafford JL; Herzog WR; Knox JG; Vogel RA
    Am J Cardiol; 1994 Jun; 73(16):1219-21. PubMed ID: 8203344
    [No Abstract]   [Full Text] [Related]  

  • 7. The responsibility of contrast media companies in the costs and benefits of radiology: giving the radiologist a real choice.
    Idée AS; Bonnemain B; Briand YP
    Acad Radiol; 1996 Apr; 3 Suppl 1():S157-9. PubMed ID: 8796550
    [No Abstract]   [Full Text] [Related]  

  • 8. Ionic vs. nonionic contrast media.
    Lloyd K
    Radiol Technol; 1994; 66(1):57-9. PubMed ID: 7997528
    [No Abstract]   [Full Text] [Related]  

  • 9. Low osmolar contrast media: a quality and cost dilemma.
    Ostrander JR
    Coll Rev; 1992; 9(2):25-39. PubMed ID: 10121945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion to nonionics packs economic punch.
    Brumbaugh J; Young SW; Cohen D
    Diagn Imaging (San Franc); 1991 Jul; 13(7):99-104. PubMed ID: 10149725
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrast media markdown.
    Bieze J
    Diagn Imaging (San Franc); 1996 Dec; 18(12):49-51, 54, 59. PubMed ID: 10163650
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-osmolality contrast media in the 1990s: prices change.
    Palmisano SM
    Radiology; 1997 May; 203(2):309; discussion 312-4. PubMed ID: 9114078
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-osmolar contrast media in the 1990s. Guidelines for urography in a cost-sensitive environment.
    Gavant ML
    Invest Radiol; 1993 Nov; 28 Suppl 5():S13-9; discussion S20. PubMed ID: 8282497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media cost analysis--I.
    Zbrozek AS
    J Am Coll Cardiol; 1994 Mar; 23(3):826; author reply 827-8. PubMed ID: 8113571
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast media cost analysis--II.
    Olukotun AY
    J Am Coll Cardiol; 1994 Mar; 23(3):826-7; author reply 827-8. PubMed ID: 8113572
    [No Abstract]   [Full Text] [Related]  

  • 16. Materials managers clip contrast media costs.
    Barlow RD
    Hosp Mater Manage; 1992 Jun; 17(6):14-5. PubMed ID: 10119199
    [No Abstract]   [Full Text] [Related]  

  • 17. Low osmolal contrast: is it a luxury we can no longer afford?
    Brinker JA
    Cathet Cardiovasc Diagn; 1994 Sep; 33(1):20-1. PubMed ID: 8001096
    [No Abstract]   [Full Text] [Related]  

  • 18. Denmark's Policy on Artificial Trans Fat and Cardiovascular Disease.
    Restrepo BJ; Rieger M
    Am J Prev Med; 2016 Jan; 50(1):69-76. PubMed ID: 26319518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision analysis to assess cost-effectiveness of low-osmolality contrast medium for intravenous urography.
    Calvo MV; Pilar del Val M; Mar Alvarez M; Domínguez-Gil A
    Am J Hosp Pharm; 1992 Mar; 49(3):577-84. PubMed ID: 1598930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-osmolality contrast agents--who needs them?
    Hirshfeld JW
    N Engl J Med; 1992 Feb; 326(7):482-4. PubMed ID: 1732775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.